Trial intelligence / Profile preview

Levobupivacaine PK in TAP block for post-cesarean analgesia

NCT02852720Phase 4Completed

Sponsor
Pontificia Universidad Católica de Chile
Start
Dec 2016
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-blind, single-arm trial of levobupivacaine in postoperative pain, sponsored by Pontificia Universidad Católica de Chile. Primary endpoint: Levobupivacaine free plasma levels. Started Dec 2016; status: completed.

02

Drugs

levobupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02852720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02852720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call